Also on this list
SnagRx
$69 semaglutide and $119 tirzepatide "locked in for life," but every payment is final.
Another provider on our semaglutide provider ranking.
Read the SnagRx review →
Provider review
Claya cost: $299/mo semaglutide
Its renewal price appears on one page — an orphaned copy of an old homepage.
Compounded semaglutide renews at $299 and tirzepatide at $399, but $299 appears only on an archived homepage nobody links to and $399 appears nowhere on the site at all.
Verified August 2026
By Marcus Webb
Transparency scorecard
1 of 4 disclosed openly
What Claya discloses about itself, read from its own pages — not estimated.
Pharmacy category stated
Not disclosed
States no federal regulatory category (503A/503B) for its pharmacy on its own site.
State coverage published
Not disclosed
Publishes no state coverage list — availability is something you learn during signup.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Not disclosed
The advertised price requires a prepay, auto-refill, or other commitment we found and named.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. A commission does not change what a review says. Full disclosure here.
At a glance
Visit ClayaPharmacy
Not categorized
Labs
Not published as a requirement, cost or cadence.
States
Not published
On this page
What it actually costs
$299/moSemaglutide, per month
What this price covers
Medication
Included
Provider visits
Not confirmed
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not disclosed
The catch — The advertised $179 is a first month that renews at $299, and the $149 is a 12-month $1,788 prepay. Its own strike-through anchor of $279 does not match its real $299 standing rate, so even the comparison figure is wrong.
See plans at ClayaPrices read from Claya's own site
What they advertise
Advertised "as low as $149/mo" semaglutide and "from $199/mo" tirzepatide on the homepage; "As low as $179/month" on the product pages; a "$279" strike-through anchor on one page. Sermorelin "as low as $199/mo," NAD+ "$199/mo," TRT "$179/mo," and brand-name pens at $1,299-$1,399.
What you actually pay
$299/mo compounded semaglutide and $399/mo compounded tirzepatide — the renewal rates its own checkout charges.
Money you will meet later
- The 12-month plans are charged in full upfront: $1,788 semaglutide and $2,388 tirzepatide.
The bottom line
Claya sells compounded semaglutide at a standing $299/month and compounded tirzepatide at $399/month, both confirmed in its own checkout. Almost none of that reaches the site. The homepage advertises "as low as $149/mo," which is a 12-month $1,788 prepay; product pages say "as low as $179/month," which is a first month renewing at $299; one page carries a $279 strike-through anchor that matches neither. The only place $299 is printed is an orphaned archived homepage, and $399 — the tirzepatide renewal rate — appears nowhere on Claya's site at all. It also markets sermorelin, NAD+ and TRT at "as low as" prices with no purchasable plan behind them.
Claya appears on our semaglutide provider ranking and our combined weight loss injections ranking.
Who it is for, and who it is not
A good fit if
- You are prepaying twelve months anyway — the $1,788 and $2,388 annual totals are real, and its ladder totals reconcile.
- You want the ladder totals to hold up: its $1,788 and $2,388 annual charges match its own per-month figures.
Look elsewhere if
- You want to know what you will be charged in month two: $299 appears only on an orphaned old homepage and $399 appears nowhere.
- You are shopping its sermorelin, NAD+ or TRT pages — all carry "as low as" prices with no purchasable plan behind them.
- You compare against its $279 strike-through anchor, which matches neither its own standing rate nor any plan it sells.
What Claya offers
Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.
Who fills your prescription
No category stated
Claya states no 503A/503B category for the pharmacy that fills your prescription.
What its own site says
Not named on anywhere on its site, and no 503A or 503B category is stated.
What's the difference between 503A and 503B?
A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.
Where you can get it
Not published
Not published as a list.
The honest cons
The part they would rather you skipped
The price Claya will actually charge you in month two is published on exactly one page of its website, and that page is an orphaned copy of an old homepage that nothing links to. Compounded semaglutide renews at $299 — a figure that appears nowhere in the live navigation, the product pages or the pricing cards, only on the archived homepage. Compounded tirzepatide renews at $399, and that number appears nowhere on Claya's site at all; it exists only inside the checkout's code. Everything the reader is shown is something else: "as low as $149" is a 12-month $1,788 prepay, "as low as $179" is a first month, and the "$279" strike-through anchor used to make $179 look like a discount does not match Claya's own standing rate either.
- Its $299 semaglutide renewal price appears only on an orphaned archived homepage.
- Its $399 tirzepatide renewal price appears nowhere on the public site at all.
- The advertised "$179/month" is a first month that renews at $299.
- Its "$279" strike-through anchor matches neither its own standing rate nor any plan it sells.
- Sermorelin, NAD+ and TRT are marketed with "as low as" prices and no purchasable plan behind them.
- No pharmacy is named and no state list is published.
How it compares
Other providers on our semaglutide provider ranking — the closest match to what Claya sells.
- SnagRx$69 semaglutide and $119 tirzepatide "locked in for life," but every payment is final.
- Live VitalEvery "monthly" GLP-1 price is a ten-week protocol divided by three.
- HealthRXEvery plan price shown up front, but no company name behind the brand.
- TrimiTwo named pharmacies and clear plan terms; the headline price is the annual plan.
- Enhance MDHonest pricing and a real 503A claim — but it isn't in all 50 states, whatever it says.
- WillowA flat price — but its own FAQ misleads on needle-free tirzepatide.
- COCollectiveThe lowest medication price here, and a $199 membership the headline omits.
- CoreAge RxSame price at every dose — but its FAQ and its refund policy disagree on refunds.
174 more providers are on our semaglutide provider ranking — see the full list. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all. The evidence below is where that gets settled.
Ready to get started?
Prices and plans in this category change often — check Claya's current pricing before you decide. Ours was read from their own site.
Facts on this page reflect Claya's own public disclosures when we last checked them. Prices and terms change without notice — confirm on Claya's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved. See our disclosure and editorial policy.
Claya
$299/mo · Semaglutide